DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Physostigmine


Collection D4 : CTD
Chemical Name Physostigmine ( From PubChem : PHYSOSTIGMINE )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
NotNotNotNotNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
275.346 g/mol 1 5 2.1677 True
Structure
InChI InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1
InChIKey PIJVFDBKTWXHHD-HIFRSBDPSA-N
Links

Gene (10 / 30)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(acetylation)AADAC
D010830
CTDdecreases(reaction)AADAC
D010830
CTDaffects(cotreatment)ACHE
D010830
CTDdecreases(activity)ACHE
D010830
CTDdecreases(activity)ACHE
D010830
CTDdecreases(reaction)ACHE
D010830
CTDdecreases(activity)ACHE
D010830
CTDdecreases(carbamoylation)ACHE
D010830
CTDdecreases(reaction)ACHE
D010830
CTDdecreases(activity)ACHE
D010830
CTDdecreases(activity)CES2
D010830
CTDaffects(binding)CHRNA4
D010830
CTDdecreases(activity)CHRNA4
D010830
CTDaffects(binding)CHRNA4
D010830
CTDdecreases(reaction)CHRNA4
D010830
CTDaffects(activity)CHRNA4
D010830
CTDincreases(reaction)CHRNA4
D010830
CTDaffects(binding)CHRNB2
D010830
CTDdecreases(activity)CHRNB2
D010830
CTDaffects(binding)CHRNB2
D010830
CTDdecreases(reaction)CHRNB2
D010830
CTDaffects(activity)CHRNB2
D010830
CTDincreases(reaction)CHRNB2
D010830
PubChem PotencyuM14.125ALDH1A1-GI(Protien) :
PubChem PotencyuM44.668EHMT2-GI(Protien) :
PubChem NoneuMESR1-GI(Protien) :
PubChem PotencyuM10.000GLS-GI(Protien) :
PubChem Ratio Potency (uM)uM30.638NFE2L2-GI(Protien) :
ChEMBLPotencynM14125.400ALDH1A1
-Target : CHEMBL3577
ChEMBLPotencynM44668.400EHMT2
-Target : CHEMBL6032
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).